FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,096 letters match. Newest first.
-
FoodSen Up Huat Seafood Trading Sdn Bhd
FDA warns Malaysian seafood processor Sen Up Huat over inadequate histamine controls in its seafood safety plan for bonito and other fish.
High risk -
DevicesNobles Medical Technology II, Inc.
FDA warns Nobles Medical Technology II over oversight failures in NobleStitch EL clinical study.
High risk -
FoodDream Wholesale, Inc
Dream Wholesale, an importer of frozen spinach and chickpeas, lacked required Foreign Supplier Verification Program (FSVP) checks.
High risk -
DrugsBell International Laboratories, Inc.
Bell International Laboratories, an OTC drugmaker, was cited for manufacturing rule violations including missing glycerin DEG/EG testing and inadequate quality oversight.
High risk -
FoodTrang Thuy Seafood Co., LTD
FDA found Trang Thuy Seafood's tuna HACCP plan did not control histamine formation after a histamine poisoning recall.
High risk -
DrugsAmman Pharmaceutical Industries
FDA warned Amman Pharmaceutical Industries after a 2023 inspection found sterile drug manufacturing and data integrity failures.
High risk -
FoodEmpacadora Bilbo S.A. DBA Bilbosa
FDA warns Ecuadorian seafood processor Bilbosa over seafood safety plan gaps for histamine and C. botulinum.
High risk -
DrugsSichuan Deebio Pharmaceutical Co. Ltd.
FDA warns Sichuan Deebio Pharmaceutical over API manufacturing and data-integrity failures.
High risk -
DrugsNingbo Poplar Daily-Use
FDA warned Ningbo Poplar Daily-Use that its OTC drugs had manufacturing quality failures in testing, component identity checks, and stability data.
High risk -
BiologicsBarkey GmbH & Co. KG
FDA warns Barkey over unapproved plasmatherm V blood thawing device and missing design risk analysis.
High risk -
DrugsQuVa Pharma, Inc.
FDA warned QuVa Pharma, a sterile drug outsourcing facility in Bloomsbury, NJ, of mold in its cleanest filling area and other CGMP failures.
High risk -
FoodLucky K.T. Co., Inc.
FDA warns Lucky K.T. noodle maker over insanitary conditions, missing food safety plan, undeclared wheat.
High risk -
FoodCurtis Jacquot dba Pacific BioLogic Co.
Pacific BioLogic's dietary supplements had manufacturing violations and disease claims making them unapproved drugs.
High risk -
FoodIowa Egg Company Inc.
Iowa Egg Company Inc. shell egg farm cited for Salmonella Enteritidis prevention, temperature, pest, testing and record violations.
High risk -
FoodIndian Groceries and Spices, Inc.
FDA says Indian Groceries and Spices lacked required foreign supplier checks for imported cumin, chili powder, and mung beans.
Medium -
FoodBattle Creek Co-op/CHS, LLC dba Progressive Nutrition
Progressive Nutrition's cattle feed contained excess urea linked to 17 cattle deaths, with preventive-control and medicated-feed violations.
High risk -
DrugsLes Importations Herbasanté Inc.
Canadian contract maker of homeopathic drugs, including children's products, skipped ingredient testing and process validation, FDA says.
High risk -
FoodInmar Supply Chain Solutions, LLC
FDA found severe rodent infestation at Inmar warehouse, adulterating stored foods, over-the-counter drugs, and devices.
High risk -
DrugsNantong Furuida Packaging Products Co., Ltd.
Nantong Furuida, an over-the-counter drug manufacturer, failed required manufacturing controls and methanol checks, leading to an FDA import alert.
High risk -
DrugsS & J International Enterprises Public Company Limited
FDA cited S & J International Enterprises for CGMP violations, data integrity failures, and limiting access to records during a drug inspection.
High risk -
FoodMexpobaja Corporation
Oakland, California importer Mexpobaja had no FSVP for its fresh produce and never verified suppliers' Produce Safety Rule compliance.
High risk -
FoodGrace Supply Inc.
Grace Supply lacked required foreign supplier verification for most imported foods and adequate Salmonella verification for shredded coconut.
High risk -
FoodA True Move LLC
FDA warns Houston importer A True Move for lacking FSVP plans for imported banana sodas, lollipops, and tomato paste.
Medium -
FoodJJR Global Inc.
FDA warns JJR Global over missing FSVP for imported chutneys and other foods.
Medium -
FoodMarion Mullet Farm
FDA warned Indiana calf dealer Marion Mullet Farm about medicated calves sold without treatment records or withdrawal compliance.
High risk -
FoodMartin Farm, Konrad Martin
Nappanee dairy farm used enrofloxacin and ceftiofur in calves contrary to labeling and kept incomplete treatment records.
High risk -
FoodCavevi Naturals LLC
FDA warns Cavevi Naturals it imported candy and Cheetos without required foreign supplier food-safety verification.
Medium -
DevicesDr. Joel Kaplan Inc.
FDA warned Dr. Joel Kaplan Inc. that its sexual health devices are unapproved, misbranded, and made under quality system violations.
High risk -
FoodComercializadora Internacional Piscicola New Your S.A
Colombian tilapia processor's HACCP plan omits Clostridium botulinum and drug-residue hazards, FDA says after remote assessment.
High risk -
DrugsWoorilife & Health
Woorilife & Health, a South Korean OTC drug maker, failed to test high-risk ingredients for DEG/EG and lacked quality-unit oversight.
High risk -
BiologicsMiMedx Group, Inc.
FDA cites MiMedx for marketing placental product AXIOFILL without BLA or IND and for CGMP failures.
High risk -
DevicesDeymed Diagnostic s.r.o.
Deymed Diagnostic s.r.o.'s BrainFeedback Pro, TruScan LT, and DuoMAG NL devices had quality system violations in design, complaints, production, and records.
Medium -
BiologicsKimera Labs, Inc.
FDA warns Kimera Labs over unapproved exosome and amniotic fluid products and serious sterile manufacturing failures.
High risk -
DrugsInopak, Ltd.
Inopak, Ltd. was warned of CGMP (current good manufacturing practice) violations after inspection: poor quality oversight of contract-made hand sanitizer and missing stability testing.
High risk -
DrugsWipro Unza Singapore Private, Limited
FDA cites Wipro Unza Singapore for refusing OTC hand sanitizer records, leading to import alert.
High risk -
DrugsPatcos Cosmetics Pvt. Ltd.
Patcos Cosmetics, an Indian OTC drug maker, failed to test high-risk ingredients for DEG/EG and lacked quality-unit oversight.
High risk -
DrugsColonial Dames Company, Ltd
FDA warns Colonial Dames of manufacturing violations and unapproved acne drug claims for Oxygenetix.
High risk -
FoodDistribuidora Jocorena Inc.
Distribuidora Jocorena lacked required foreign supplier checks for imported corn flour, frozen tamales, and beans, FDA says.
Medium -
DrugsSudesan Temizlik Urunleri Ve Ambalaj Sanaryi Ticaret Anomin Sirketi
FDA warns Turkish hand sanitizer maker Sudesan of CGMP violations and adulterated drugs.
High risk -
DevicesSonesta Medical AB
FDA warned Sonesta Medical AB that its radiographic and cystometric tables violated device quality system rules.
Medium -
FoodKyawkhin Inc.
Kyawkhin Inc. had no foreign supplier verification program for imported chili paste, peanut snack, and beverage base.
Medium -
FoodDesserts by Helen, Inc.
FDA cited Desserts by Helen for unsanitary conditions and cleaning failures at its Louisville ready-to-eat bakery.
High risk -
DevicesFresenius Medical Care AG & Co. KGaA
FDA warns Fresenius over delayed fixes and reporting for PCB leaching from silicone tubing in hemodialysis machines.
High risk -
DrugsIntas Pharmaceuticals Limited
FDA cited Intas Pharmaceuticals for CGMP violations, including manipulated visual inspection records and inadequate sterile-drug controls.
High risk -
DrugsAmLion Toothpaste Mfg. Sdn. Bhd.
FDA cites AmLion Toothpaste in Malaysia for CGMP failures, including no testing of glycerin and sorbitol for DEG/EG; firm stays on import alert.
High risk -
DrugsCipla Limited
FDA warned Cipla about unresolved albuterol inhaler delivery complaints and contamination in sterile manufacturing at its Indore site.
High risk -
DrugsCerci Kozmetik Ve Otel Ekipmanlari Pazarlama Ic Ve Dis Ticaret Limited Sirketi
FDA: Turkish OTC drug maker Cerci shipped to the U.S. without finished-product identity and strength testing.
High risk -
DrugsXiamen Wally Bath Manufacture Co., Ltd.
FDA warns Xiamen Wally Bath over current good manufacturing practice failures for over-the-counter hand sanitizer, including raw material and release testing gaps.
High risk -
DrugsBrenntag Great Lakes, LLC
Brenntag Great Lakes failed to prevent cross-contamination of OTC hand sanitizer made on equipment shared with industrial chemicals.
High risk -
DevicesWello Inc.
FDA cited Wello Inc. for misbranded welloStationX devices because labels lacked unique device identifiers and required GUDID data were not submitted.
Low